KPJ Healthcare Berhad (KLSE:KPJ)
Malaysia · Delayed Price · Currency is MYR 2.700
0.00 (0.00%)
At close: Aug 28, 2026
KPJ Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,514 | 4,258 | 3,899 | 3,419 | 2,868 | 2,590 | |
Revenue Growth | 11.11% | 9.21% | 14.06% | 19.18% | 10.76% | 8.03% |
Cost of Revenue | 2,492 | 2,360 | 2,151 | 1,987 | 1,696 | 1,664 |
Gross Profit | 2,022 | 1,898 | 1,749 | 1,432 | 1,172 | 925.91 |
Selling, General & Admin | 1,324 | 1,237 | 1,105 | 959.46 | 795.13 | 694.07 |
Other Operating Expenses | -38.61 | -42.53 | -27.31 | -67.34 | -28.6 | -24.01 |
Operating Expenses | 1,285 | 1,194 | 1,078 | 892.12 | 766.53 | 670.07 |
Operating Income | 736.77 | 703.86 | 671.04 | 539.79 | 405.54 | 255.85 |
Interest Expense | -199.72 | -194.36 | -197.02 | -204.89 | -194.34 | -166.74 |
Interest & Investment Income | 26.92 | 21.13 | 22.1 | 20.15 | 12.14 | 8.55 |
Earnings From Equity Investments | 57.2 | 48.76 | 49.36 | 46.76 | 47.76 | 25.86 |
EBT Excluding Unusual Items | 621.17 | 579.38 | 545.48 | 401.81 | 271.11 | 123.52 |
Impairment of Goodwill | - | - | - | - | - | -4.03 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.56 |
Asset Writedown | -10.02 | -10.02 | -8.09 | -20.8 | 6.71 | 3.34 |
Pretax Income | 611.15 | 569.36 | 537.39 | 381.01 | 277.82 | 123.39 |
Income Tax Expense | 173.15 | 167.82 | 171.51 | 78.41 | 75.89 | 51.01 |
Earnings From Continuing Operations | 438 | 401.54 | 365.87 | 302.6 | 201.93 | 72.38 |
Earnings From Discontinued Operations | - | -0.09 | 21.63 | -17.88 | -11.63 | - |
Net Income to Company | 438 | 401.45 | 387.5 | 284.71 | 190.31 | 72.38 |
Minority Interest in Earnings | -37.62 | -35.52 | -33.69 | -21.31 | -23.32 | -17.59 |
Net Income | 400.38 | 365.93 | 353.82 | 263.41 | 166.98 | 54.79 |
Net Income to Common | 400.38 | 365.93 | 353.82 | 263.41 | 166.98 | 54.79 |
Net Income Growth | 9.98% | 3.42% | 34.32% | 57.75% | 204.79% | -50.40% |
Shares Outstanding (Basic) | 4,405 | 4,374 | 4,364 | 4,361 | 4,341 | 4,292 |
Shares Outstanding (Diluted) | 4,408 | 4,377 | 4,364 | 4,361 | 4,444 | 4,416 |
Shares Change | 0.94% | 0.30% | 0.07% | -1.86% | 0.64% | -0.99% |
EPS (Basic) | 0.09 | 0.08 | 0.08 | 0.06 | 0.04 | 0.01 |
EPS (Diluted) | 0.09 | 0.08 | 0.08 | 0.06 | 0.04 | 0.01 |
EPS Growth | 8.90% | 3.11% | 34.20% | 60.71% | 203.09% | -50.00% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 687.5 | 622.92 | 460.44 | 420.04 | 225.59 | 195.65 |
Free Cash Flow Per Share | 0.16 | 0.14 | 0.11 | 0.10 | 0.05 | 0.04 |
Dividend Per Share | 0.046 | 0.041 | 0.042 | 0.031 | 0.020 | 0.005 |
Dividend Growth | 15.75% | -0.48% | 33.87% | 55.00% | 263.64% | -54.17% |
Gross Margin | 44.79% | 44.57% | 44.84% | 41.88% | 40.86% | 35.75% |
Operating Margin | 16.32% | 16.53% | 17.21% | 15.79% | 14.14% | 9.88% |
Profit Margin | 8.87% | 8.59% | 9.07% | 7.70% | 5.82% | 2.11% |
Free Cash Flow Margin | 15.23% | 14.63% | 11.81% | 12.29% | 7.86% | 7.55% |
EBITDA | 976.88 | 936.45 | 879.42 | 737.85 | 595.48 | 441.63 |
EBITDA Margin | 21.64% | 21.99% | 22.55% | 21.58% | 20.76% | 17.05% |
D&A For EBITDA | 240.11 | 232.6 | 208.38 | 198.06 | 189.93 | 185.78 |
EBIT | 736.77 | 703.86 | 671.04 | 539.79 | 405.54 | 255.85 |
EBIT Margin | 16.32% | 16.53% | 17.21% | 15.79% | 14.14% | 9.88% |
Effective Tax Rate | 28.33% | 29.47% | 31.92% | 20.58% | 27.32% | 41.34% |